BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 28, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sativex sublingual cannabis extract spray regulatory update

GW Pharmaceuticals and partner Bayer said the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) approved an MAA for Sativex to treat spasticity due to multiple sclerosis (MS). The approval triggers a £10...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >